Are you looking for creative ways to reach and engage your healthcare audience?
Partner with medwireNews and see how our content and tactics can boost your independent educational activities to optimize your goals.
Specialists in medical education and content creation, we provide solutions that grab the attention of healthcare professionals and inform them on key messages in convenient, easily accessible and timely formats.
Our services can help you build trusted relationships with your healthcare professional audience by supporting them in the knowledge they need to stay up to date and ensure the continued learning essential to improving patient care.
- 09-12-2024|
- |
- Oncology |
Hypofractionated proton beam therapy regimen feasible for glioblastoma in older patients
A short course of hypofractionated proton beam therapy given alongside temozolomide may offer an improvement in overall survival for patients aged 65 years and older with a new diagnosis of glioblastoma, suggesting findings from a “hypothesis-generating” study.
- 02-12-2024|
Regular screening helps reduce symptom burden in paediatric cancer patients
Research shows that young people with a recent diagnosis of cancer benefit from completing an online symptom screening survey three times a week to help direct care.
- 27-11-2024|
- |
- Oncology |
Routine postoperative imaging may improve pancreatic cancer survival
Research suggests that patients who are invited for routine imaging after pancreatic ductal adenocarcinoma resection have significantly longer overall survival than those who undergo imaging only after the development of symptoms.
- 15-11-2024|
- |
- Oncology |
Impact of haematological malignancy on pregnancy revealed
Women who are diagnosed with haematological malignancies during pregnancy have similar overall survival to peers diagnosed within a year of their pregnancy ending, indicates research published in The Lancet Haematology.
- 06-11-2024|
- |
- Neurology |
Adjunctive fasudil ‘considered safe’ for amyotrophic lateral sclerosis
The Rho-associated kinase inhibitor fasudil as an adjunct to riluzole is well tolerated for the treatment of patients with amyotrophic lateral sclerosis, indicate phase 2 findings from the ROCK-ALS study.
- 28-10-2024|
- |
- Oncology |
- Paediatrics |
European retinoblastoma report shows stabilised incidence, high 5-year survival
The incidence of retinoblastoma in children in Europe stabilised between 2000 and 2013, say EUROCARE-6 Working Group investigators who report high 5-year survival rates in this population.
- Gastroenterology
- Conference Coverage & Reporting, Expert Interviews & Discussion
- Oncology
- Conference Coverage & Reporting
- Oncology
- News Services
- Diabetes
- Featured Content Creation
- Oncology
- Expert Interviews & Discussion
- Gastroenterology
- Conference Coverage & Reporting
- Rheumatology
- Expert Interviews & Discussion
- Neurology
- Conference Coverage & Reporting